The authors further demonstrated that MARCH5 mRNA and protein expression in either HCC or HBV-mediated HCC liver tissue specimens of clinical cases were significantly downregulated in a later stage (Stage IV) of cancers with high expression of HBx [50]. The gene discussed is MARCHF5; the disease is hepatocellular carcinoma.